Literature DB >> 1616949

Synthesis, conformation, biodistribution, and in vitro cytotoxicity of daunomycin-branched polypeptide conjugates.

F Hudecz1, J A Clegg, J Kajtár, M J Embleton, M Szekerke, R W Baldwin.   

Abstract

Daunomycin has been attached to various structurally related synthetic branched polypeptides with a polylysine backbone, using its acid-labile cis-aconityl derivative (cAD). Due to the importance of the side-chain structure in alpha-helix formation and immunological and pharmacological properties of branched polypeptides, we have investigated the conformation, biodistribution, and in vitro cytotoxicity of cAD-carrier conjugates with polypeptides containing amino acid residues of different identity and/or configuration at the side-chain end (XAK type) or at the position next to the polylysine backbone (AXK type), where X = Leu, D-Leu, Pro, Glu, or D-Glu. According to CD studies, polycationic conjugates with hydrophobic Leu in the side chains could assume a highly ordered conformation, while amphoteric conjugates containing Glu proved to be unordered in PBS. The reduction of in vitro cytotoxic activity of cAD by conjugation to carriers and the biodistribution profile of the conjugates were found to be dependent predominantly on the charge properties and on the side-chain sequence of the carrier polypeptide. It was demonstrated that by proper combination of structural elements of the carrier molecule, it is feasible to construct a cAD-branched polypeptide conjugate with significantly prolonged blood survival and with no reduction in in vitro cytotoxicity of the drug.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616949     DOI: 10.1021/bc00013a008

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

1.  Scintigraphic evaluation of the pharmacokinetics of a soluble polymeric drug carrier.

Authors:  M V Pimm; A C Perkins; F Hudecz
Journal:  Eur J Nucl Med       Date:  1992

2.  Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts.

Authors:  B Vincze; I Pályi; D Daubner; A Kálnay; G Mezö; F Hudecz; M Szekerke; I Teplán; I Mezö
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins.

Authors:  M V Pimm; F Hudecz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.